Mother-Infant Linked Longitudinal Surveillance

CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD23-2303, Mother-Infant Linked Longitudinal Surveillance. The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 1, 2023. The purpose of this NOFO is to conduct mother-infant linked longitudinal surveillance on key exposures and outcomes of public health interest through both a clinic- and health department-based approach. These approaches collect health information from various sources and/or conduct data linkages, resulting in robust data across multiple years from pregnancy into childhood. The cooperative agreement intends to sustain, improve, and expand surveillance efforts from clinical sites and health departments related to mother-infant linked longitudinal data to ensure timely reporting of key exposures and outcomes that impact pregnant people and infants, to improve data quality and share evolving outcome data, to innovate clinical strategies, and build a strong collaborative network. Priority exposures and outcomes of public health interest may include, but not limited to medication for opioid use disorder, neonatal abstinence syndrome, cytomegalovirus, stillbirths (not intended to be longitudinal), and other conditions that may have serious impacts on pregnant people and infants. Strategic areas of focus may include advancing interoperability, data quality and informatics, and innovating and strengthening public health reporting. Focus areas may also include monitoring maternal, infant, and child outcomes including follow-up for diverse clinical and neurodevelopmental outcomes of children exposed to infectious and non-infectious threats that are not currently national notifiable.
Categories: Health.